Assessment of impact of Rosuvastatin in patients with COPD: A Clinical Study

Journal Title: Journal of Advanced Medical and Dental Sciences Research - Year 2018, Vol 6, Issue 6

Abstract

Background:It has become increasingly recognized that chronic obstructive pulmonary disease (COPD) is a systemic disorder characterized not only by pulmonary but also by systemic inflammation.Statins, also known as 3-Hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors, are the most common medications used to treat hyperlipidaemia. Hence; we conducted the present investigation to assess the effect of rosuvastatin in patients with chronic obstructive pulmonary disease (COPD). Materials & methods: The present investigation included evaluation of effect of rosuvastatin in patients with chronic obstructive pulmonary disease (COPD). A total of 30 patients were included in the present study. Random distribution of all the patients was done into two study groups, with 15 patients in each group. The first group received rosuvastatin 10 mg orally once daily and the second group received placebo matching the active drug. Evaluation of the patients was done after 90 days for assessing the outcome. Following Pulmonary function indices were assessed for assessing the outcome:Forced vital capacity (FVC),Forced expiratory volume at 1 s (FEV1), and FEV1/FVC.Comparison of the results was done by SPSS software. Results: A total of 30 patients with COPD were included in the present study. Mean age of the patients of the placebo group and the Rosuvastatin group was found to be 60.5 years and 62.1 years respectively. We observed a significant alteration in the mean pulmonary functional indices while comparing the values in the placebo group and Rosuvastatin group (P-value < 0.05). Conclusion: A significant decrease in the COPD exacerbation was observed in patients on Rosuvastatin therapy.

Authors and Affiliations

Roohi Sharma, Zahid Gilani, Sundas Sundas

Keywords

Related Articles

PREVALENCE OF ROOT CARIES AND PERIODONTAL DISEASES IN ADULT AND OLDER PEOPLE RESIDING IN IMADOL, LALITPUR, NEPAL

Background: Increased life expectancy and improved oral health conditions may increase in the number of adults and the elderly with higher proportions of preserved or retained teeth and, subsequently, greater exposure to...

Assessment of Position of Mandibular and Genial Foramen in in North Indian Human Mandibles

Introduction: The mandibular foramen is a prominent foramen and its knowledge is of paramount importance during dental procedures of lower jaw. Most common of the accessory foramina are the foramina present on the intern...

Malignant Transformation of Oral Leukoplakia: Study of 50 Patients

Background: Oral leukoplakia (OL) is the best-known potentially malignant disorder. The objective of this study is to estimate the rate of malignant transformation in a patients with leukoplakia for more than 5 years and...

Awareness for dental implants among Population of Bhopal: A cross sectional Study

Introduction: Dental Implant is a successful treatment modality for replacing single tooth or multiple teeth. It also prevent the natural teeth contrary to fixed partial denture therapy. Comfort level is high in implant...

Calcifying Epithelial Odontogenic Cyst - A Case Report

Calcifying odontogenic cyst or Gorlin cyst, was first described by Gorlin. It is an unusual and unique lesion, which may show characteristics of both a solid neoplasm and a cyst.This lesion occurs intraosseously as well...

Download PDF file
  • EP ID EP545280
  • DOI -
  • Views 117
  • Downloads 0

How To Cite

Roohi Sharma, Zahid Gilani, Sundas Sundas (2018). Assessment of impact of Rosuvastatin in patients with COPD: A Clinical Study. Journal of Advanced Medical and Dental Sciences Research, 6(6), 46-48. https://europub.co.uk/articles/-A-545280